Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors [EARLY_Phase 1]
Clinical trial update describing a Phase 1 study of Intravenous IDOV-SAFETM in patients with advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer [Phase 1]
Phase 1 study evaluating BTX-A51 in patients with advanced solid tumors and metastatic breast cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: A Study of SHR-4375 in Subjects With Solid Tumors [Phase 1, Phase 2]
A clinical trial update indicates that SHR-4375 is being studied in Phase 1/2 for patients with solid tumors, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: AMT-116 in Patients with Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating AMT-116 in patients with advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors [NA]
This clinical trial update notes the completion of a study evaluating PSMA PET/CT as an imaging biomarker in metastatic castration-resistant…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults [Phase 2]
A Phase 2 prospective, single-arm clinical study evaluating liposomal mitoxantrone in relapsed or refractory solid tumors in children, adole…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors [Phase 1]
Phase I, genotype-guided irinotecan study in a VIT regimen for pediatric relapsed/refractory solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Using of Virtual Reality to Relieve Procedural Pain in Pediatric Oncology. [NA]
A completed clinical trial evaluating virtual reality as a non-drug method to relieve procedural pain in pediatric cancer patients. The stud…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors [Phase 1]
Phase I study of LNF2007 as monotherapy in patients with advanced solid tumors is not yet recruiting. Sponsor: Shandong New Time Pharmaceuti…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: MMP14(MT1-MMP) Targeting Bicyclic Peptide Probe for PET Imaging in Solid Tumors
A clinical trial registry entry describes a bicyclic peptide probe targeting MMP14 (MT1-MMP) for PET imaging in solid tumors, with recruitme…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
A Phase Ib/II clinical trial evaluating JS015 in combination therapy for advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: Intratumoral CAN2109 in Subjects With Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating intratumoral CAN2109 in adults with solid tumors and lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating the safety, pharmacokinetics and preliminary efficacy of PRJ1-3024 in patients with advanced solid tumors; recrui…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Neurocognitive Risks in Children With Solid Tumors
A clinical trial update indicating that recruitment is ongoing for a study examining neurocognitive risks in children with solid tumors.
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: A Phase II Study of SHR-4602 as Montherapy or in Combination With Other Anti-tumor Therapies in Advanced Solid Tumors [Phase 2]
Phase II study of SHR-4602 as monotherapy or in combination with other anti-tumor therapies for advanced solid tumors; the trial status is n…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) [Phase 1, Phase 2]
GI Innovation's GI-102 is being studied in a phase 1/2 trial as a single agent and in combination with pembrolizumab or trastuzumab deruxtec…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Phase I Clinical Study of MBS301 in Treatment of HER2 Positive Recurrent or Metastatic Malignant Solid Tumor [Phase 1]
Phase I clinical trial update for MBS301 in HER2-positive recurrent or metastatic malignant solid tumors; study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: A Phase 2 Clinical Study of ABSK061 and ABSK043 [Phase 2]
Abbisko Therapeutics is recruiting for a Phase 2 study of ABSK061 and ABSK043 in multiple cancers, including HER2-positive gastric/gastroeso…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating PF-07220060 in combination with PF-07104091 for breast cancer and solid tumors. The study is currently A…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial [Phase 1]
This clinical trial update describes a Phase 1 rollover study for adult subjects who completed participation in the IMSA101-101 trial, spons…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: The Psychological Impact of COVID-19 on Patients with Solid Malignancies: a Single-Institution Survey Study
The Christie NHS Foundation Trust completed a single-institution survey evaluating the psychological impact of COVID-19 on patients with sol…
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors [Phase 1, Phase 2]
First-in-human Phase 1/2 trial of EGL-001 in adults with selected advanced or metastatic solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: A Study of XZB-0004 in Patients With Solid Tumors [Phase 1]
Phase 1 study of XZB-0004 in patients with solid tumors, including non-small cell lung cancer, is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating SHR-7787 injections in patients with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy. [NA]
A multi-cohort clinical trial evaluating Efbemalenograstim Alfa Injection to prevent ANC reduction in solid tumor patients following immune-…